First Time Loading...

Amplitude Surgical SA
PAR:AMPLI

Watchlist Manager
Amplitude Surgical SA Logo
Amplitude Surgical SA
PAR:AMPLI
Watchlist
Price: 2.9 EUR 1.4% Market Closed
Updated: May 9, 2024
Section:
 

Wall Street
Price Targets

AMPLI Price Targets Summary
Amplitude Surgical SA

Wall Street analysts forecast AMPLI stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for AMPLI is 4.25 EUR .

AMPLI Lowest Forecast
Wall Street Target
Not Available
AMPLI Average Forecast
Wall Street Target
4.25 EUR
47% Upside
AMPLI Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
4.25 EUR
47% Upside
Highest
Price Target
Not Available
Amplitude Surgical SA Competitors:
Price Targets
CEVI
CellaVision AB
12% Upside
PEN
Penumbra Inc
35% Upside
SEZI
Senzime AB (publ)
96% Upside
7575
Japan Lifeline Co Ltd
21% Upside
CEVI
CellaVision AB
12% Upside
PEN
Penumbra Inc
35% Upside
SEZI
Senzime AB (publ)
96% Upside
7575
Japan Lifeline Co Ltd
21% Upside
V
100120
Vieworks Co Ltd
40% Upside
SIBN
SI-BONE Inc
67% Upside
J
300529
Jafron Biomedical Co Ltd
8% Upside
7716
Nakanishi Inc
36% Upside

Revenue
Forecast

Revenue Estimate
Amplitude Surgical SA

For the last 8 years the compound annual growth rate for Amplitude Surgical SA's revenue is 4%. The projected CAGR for the next 3 years is -5%.

4%
Past Growth
-5%
Estimated Growth
Estimates Accuracy
-3%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Amplitude Surgical SA

For the last 8 years the compound annual growth rate for Amplitude Surgical SA's operating income is 12%.

12%
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-59%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Amplitude Surgical SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average
What are analyst estimates?

See Also

Summary
AMPLI intrinsic value, competitors valuation, and company profile.
DCF Valuation
AMPLI stock valuation using Discount Cash Flow valuation method.
Relative Valuation
AMPLI stock valuation using valuation multiples.
Wall Street Estimates
AMPLI price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
AMPLI stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is AMPLI's stock price target?
Price Target
4.25 EUR

According to Wall Street analysts, the average 1-year price target for AMPLI is 4.25 EUR .

What is Amplitude Surgical SA's Revenue forecast?
Projected CAGR
-5%

For the last 8 years the compound annual growth rate for Amplitude Surgical SA's revenue is 4%. The projected CAGR for the next 3 years is -5%.

ALPHA SPREAD
Join more than 135,800+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.